Kirkland & Ellis LLP provides legal services. The company counsels clients in complex litigation, corporate and tax, intellectual property and restructuring matters. The company was founded in 1909 and is headquartered in Chicago, IL.
Phase4 is a multi-disciplinary team with a range of medical, scientific, legal and financial backgrounds. Integral to the team is a network of senior consultants and advisors with extensive operating experience at a senior level in pharmaceutical and biotechnology companies.The firm invests in late-stage emerging healthcare companies, typically in the second or third financing rounds, where an IPO is foreseeable over a two- to three-year period.They seek companies with products that address unmet medical needs, particularly companies with therapeutic products that are in, or are about to enter, clinical trials. The potential market for the product must be in line with the risk of the investment.Phase4 typically acts as lead investor and seeks to invest in companies with defendable intellectual property, a proven business model and entrepreneurs who are experts in their fields as well as seasoned business people.The firm invests in companies that have the backing of other investors who share similar investment values. They are an active investor which seeks representation on the Board of Directors, providing guidance and support and seeking to add value to investee companies through their relationships with global investors, corporates, their network of advisors and sector knowledge.